Skip to main content
. 2024 Mar 18;15:75. doi: 10.1186/s13244-024-01641-8

Table 2.

Left ventricular characteristics and fractal dimension in each phase

Characteristics All subjects (n = 200) Non MACE (n = 163) MACE (n = 37) p value
Acute phase
 CMR parameters
  Heart rate (beats/min) 74.6 ± 11.3 73.8 ± 11.4 78.2 ± 10.6 0.03
  LVEF (%) 49.13 ± 11.23 49.8 ± 10.58 46.21 ± 13.49 0.14
  LVMi (g/m2) 64.61 ± 12.23 63.76 ± 10.92 68.34 ± 16.51 0.12
  LVEDVi (mL/m2) 81.22 ± 20.44 78.98 ± 16.64 91.12 ± 30.66 0.03
  LVESVi (mL/m2) 42.54 ± 19.98 40.25 ± 14.39 52.63 ± 33.85 0.04
  LVSVi (mL/m2) 38.68 ± 9.36 38.73 ± 9.11 38.48 ± 10.52 0.90
  Infarct size (% of LV) 26.51 ± 11.71 24.51 ± 10.46 35.33 ± 12.97  < 0.001
  Infarct transmural extent (%) 95 (90, 100) 95 (90, 100) 100 (95, 100) 0.12
  Edema size (% of LV) 37.02 ± 13.54 36.5 ± 13.57 39.32 ± 13.38 0.25
  LV thrombus, n (%) 28, 14 20, 12.3 8, 21.6 0.19
  LV aneurysm, n (%) 24, 12 20, 12.3 4, 10.8 0.99
  MVO/IMH, n (%) 130, 65 109, 66.9 21, 56.8 0.24
  Papillary infarction, n (%) 34, (17) 30 (18.4) 4 (10.8) 0.46
FD measures
 Global FD 1.253 ± 0.049 1.251 ± 0.048 1.260 ± 0.052 0.35
 Infarct area FD 1.209 ± 0.08 1.211 ± 0.079 1.199 ± 0.070 0.37
 Remote area FD 1.243 ± 0.058 1.244 ± 0.058 1.236 ± 0.054 0.44
Subacute phase
 CMR parameters
  Heart rate (beats/min) 67.8 ± 10.7 66.9 ± 10.6 71.6 ± 10.4 0.02
  LVEF (%) 50.35 ± 11.54 51.37 ± 10.67 45.86 ± 14.08 0.03
  LVMi (g/m2) 60.65 ± 12.34 59.91 ± 11.19 63.92 ± 16.28 0.16
  LVEDVi (mL/m2) 82.53 ± 21.85 79.46 ± 16.82 96.08 ± 33.69 0.006
  LVESVi (mL/m2) 42.29 ± 20.28 39.29 ± 14.48 55.53 ± 33.3 0.006
  LVSVi (mL/m2) 40.24 ± 9.09 40.17 ± 9.24 40.55 ± 8.51 0.81
  Infarct size (% of LV) 21.2 ± 10.32 19.41 ± 8.97 29.09 ± 12.18  < 0.001
  Infarct transmural extent (%) 95 (75, 100) 90 (75, 100) 100 (90, 100) 0.10
  LV thrombus, n (%) 11, 5.5 10, 6.1 1, 2.7 0.49
  LV aneurysm, n (%) 34, 17 26, 15.9 8, 21.6 0.47
  MVO/IMH, n (%) 80, 40 62, 38.0 18, 48.6 0.26
FD measures
 Global FD 1.239 ± 0.046 1.244 ± 0.048 1.219 ± 0.033  < 0.001
 Infarct area FD 1.178 ± 0.069 1.182 ± 0.071 1.16 ± 0.057 0.01
 Remote area FD 1.239 ± 0.056 1.243 ± 0.056 1.219 ± 0.05 0.01
 ΔGlobal FD -0.014 ± 0.037 -0.008 ± 0.034 -0.041 ± 0.037  < 0.001
 ΔInfarct area FD -0.031 ± 0.036 -0.029 ± 0.036 -0.033 ± 0.036 0.15
 ΔRemote area FD -0.003 ± 0.034 -0.001 ± 0.033 -0.017 ± 0.035 0.01
Chronic phase
 CMR parameters
  Heart rate (beats/min) 66.3 ± 11.0 65.6 ± 10.7 69.2 ± 11.9 0.10
  LVEF (%) 50.1 ± 16.01 51.31 ± 16.09 44.8 ± 14.71 0.02
  LVMi (g/m2) 59.62 ± 12.04 58.84 ± 10.4 63.09 ± 17.29 0.16
  LVEDVi (mL/m2) 82.74 ± 22.52 79.48 ± 17.65 97.11 ± 33.77 0.004
  LVESVi (mL/m2) 42.57 ± 22.11 39.19 ± 16.06 57.5 ± 35.51 0.002
  LVSVi (mL/m2) 40.17 ± 9.87 40.29 ± 10 39.62 ± 9.4 0.70
  Infarct size (% of LV) 19.06 ± 9.99 17.38 ± 8.65 26.48 ± 12.07  < 0.001
  Infarct transmural extent (%) 95 (75, 100) 95 (75, 100) 100 (85, 100) 0.14
  LV thrombus, n (%) 6, 3 5, 3.1 1, 2.7 0.99
  LV aneurysm, n (%) 35, 17.5 26, 15.9 9, 24.3 0.25
  MVO/IMH, n (%) 33, 16.5 27, 16.5 6, 16.2 0.72
FD measures
 Global FD 1.230 ± 0.045 1.233 ± 0.047 1.216 ± 0.034 0.01
 Infarct area FD 1.169 ± 0.068 1.174 ± 0.069 1.149 ± 0.055 0.02
 Remote area FD 1.233 ± 0.057 1.237 ± 0.058 1.217 ± 0.048 0.04
 ΔGlobal FD -0.023 ± 0.047 -0.018 ± 0.046 -0.044 ± 0.04 0.001
 ΔInfarct area FD -0.040 ± 0.044 -0.037 ± 0.044 -0.040 ± 0.031 0.26
 ΔRemote area FD -0.009 ± 0.044 -0.007 ± 0.045 -0.019 ± 0.037 0.09

Data are mean ± standard deviation for normally distributed variables, median and interquartile range (in parentheses) for skewed variables

MACE Major adverse cardiovascular events, LVEF Left ventricular ejection fraction, LVEDVi Left ventricular end-diastolic volume index, LVESVi Left ventricular end-systolic volume index, LVMi Left ventricular mass index, LVSVi Left ventricular stroke volume index, MVO Microvascular obstruction, IMH Intramyocardial hemorrhage, LVT Left ventricular thrombus, FD Fractal dimension